<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-PNKHQNO0</identifier><date>2011</date><creator>Mlakar, Jernej</creator><relation>documents/doc/P/URN_NBN_SI_doc-PNKHQNO0_001.htm</relation><relation>documents/doc/P/URN_NBN_SI_doc-PNKHQNO0_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PNKHQNO0_001.txt</relation><format format_type="issue">3</format><format format_type="volume">80</format><format format_type="type">article</format><format format_type="extent">str. 163-170</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">2978417</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PNKHQNO0</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">imatinib</subject><subject language_type_id="slv">kronična mieloična levkemija</subject><subject language_type_id="slv">levkemija</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Imatinib plasma concentration - a new laboratory parameter for monitoring the treatment of Slovenian patients with chronic myeloid leukemia</title><title>Koncentracija imatiniba v plazmi - nov laboratorijski podatek pri spremljanju zdravljenja slovenskih bolnikov s kronično mieloično levkemijo</title></Record>